FDA grants tenative approval for another Aurobindo Pharma HIV drug

ROCKVILLE, Md. The Food and Drug Administration has granted tentative approval to a generic version of an HIV drug, agency records show.

The FDA gave the tentative approval to Aurobindo Pharma’s lopinavir/ritonavir tablets in the 100 mg/25 mg and 200 mg/50 mg strengths. The tablets are a generic version of Abbott Labs’ Kaletra, marketed in developing countries under the name Aluvia.

Kaletra will come off patent in 2013, according to the FDA’s Orange Book.

Login or Register to post a comment.